Due: November 30, 2023 This RPI focuses on surveying the current state of engineering and medical prototypes, knowledge products, and manufacturing capacity related to military dental research. Project information papers will be reviewed by the Sponsor Read More
Due: November 15, 2023 Areas of Need: Unmanned Aerial Systems and Payloads for Infantry Support Weapons Payloads for Unmanned Naval Platforms Weapon Learning and Artificial Intelligence Compact Mobile HPM Weapon System Prototype High Accuracy Direction Read More
Due: November 20, 2023 AutoDoc Request for Project Proposals (RPP) focused on identifying a system of sensor suites that can reliably and passively collect the core data needed to identify casualty status, key tasks performed Read More
DUE: November 5, 2026 Furthering the science of personal health informatics by providing meaningful and actionable insights to individuals through innovative personal health data collection, integration, analysis, and personalized risk assessments and interpretation.
DUE: February 23, 2024 Funding opportunity supporting impactful, large marine debris removal projects that will improve the resilience of the coastal and marine environment and implement strategies to prevent the re-accumulation of marine debris.
DUE: September 7, 2026 The National Cancer Institute invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research.
DUE: August 31, 2028 Funding opportunity to develop strategies and interventions to improve diagnostic safety in the heterogenous ambulatory care environment.
DUE: September 7, 2026 Seeking applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy.
DUE: January 7, 2027 Funding available to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk
DUE: February 7, 2024 Funding available to provide a proof-of-principle for a novel strategy for Alzheimer Disease and Alzheimer Related Dementias (AD/ADRD) immunotherapies.
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.